Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AIMTSE:NIF.UNTSE:OLYNYSEARCA:XLY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIMAIM ImmunoTech$0.09-22.3%$0.10$0.06▼$0.47$6.61M0.76574,348 shs2.31 million shsNIF.UNNoranda Income FundC$0.00C$0.26▼C$1.99C$73.86M1.46171,754 shs9,593 shsOLYOlympia Financial GroupC$111.79+1.6%C$105.20C$89.90▼C$112.90C$269.01M0.271,647 shs2,035 shsXLYConsumer Discretionary Select Sector SPDR Fund$214.30+0.2%$199.45$166.48▼$240.28$21.13B1.233.46 million shs4.39 million shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIMAIM ImmunoTech0.00%0.00%0.00%-23.90%-74.75%NIF.UNNoranda Income Fund0.00%0.00%0.00%0.00%0.00%OLYOlympia Financial Group0.00%+3.73%+4.06%+2.32%+7.05%XLYConsumer Discretionary Select Sector SPDR Fund0.00%+1.51%+6.16%+0.88%+21.52%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAIMAIM ImmunoTech1.612 of 5 stars3.50.00.00.00.61.70.6NIF.UNNoranda Income FundN/AN/AN/AN/AN/AN/AN/AN/AOLYOlympia Financial Group3.126 of 5 stars3.50.02.50.00.03.31.3XLYConsumer Discretionary Select Sector SPDR FundN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIMAIM ImmunoTech 3.00Buy$2.752,908.75% UpsideNIF.UNNoranda Income Fund 0.00N/AN/AN/AOLYOlympia Financial Group 3.00BuyC$147.9132.31% UpsideXLYConsumer Discretionary Select Sector SPDR Fund 2.65Moderate Buy$214.30N/ACurrent Analyst Ratings BreakdownLatest NIF.UN, XLY, OLY, and AIM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/21/2025OLYOlympia Financial GroupFundamental ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuyC$147.913/11/2025OLYOlympia Financial GroupFundamental ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuyC$143.52(Data available from 6/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIMAIM ImmunoTech$170K38.87N/AN/A$0.20 per share0.46NIF.UNNoranda Income FundC$887.61M0.00N/A7.50C$4.54 per share0.00OLYOlympia Financial GroupC$102.64M2.62C$9.59 per share11.66C$16.72 per share6.69XLYConsumer Discretionary Select Sector SPDR FundN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIMAIM ImmunoTech-$28.96M-$0.31N/AN/AN/A-12,594.21%-421.73%-147.54%N/ANIF.UNNoranda Income FundC$12.88MC$0.355.63N/AN/A1.45%6.26%7.05%N/AOLYOlympia Financial GroupC$24.45MC$10.1611.00∞N/A23.82%64.95%35.88%N/AXLYConsumer Discretionary Select Sector SPDR FundN/AN/A25.86∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIMAIM ImmunoTechN/AN/AN/AN/AN/ANIF.UNNoranda Income FundN/AN/AN/AN/AN/AOLYOlympia Financial GroupC$7.206.44%N/A70.86%N/AXLYConsumer Discretionary Select Sector SPDR Fund$1.770.83%N/AN/AN/ALatest NIF.UN, XLY, OLY, and AIM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/21/2025OLYOlympia Financial GroupMonthlyC$0.606.99%5/21/20255/30/20255/30/20254/17/2025OLYOlympia Financial GroupMonthlyC$0.606.94%4/17/20254/30/20254/30/20253/20/2025OLYOlympia Financial GroupMonthlyC$0.606.83%3/20/20253/31/20253/31/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAIMAIM ImmunoTech0.050.750.75NIF.UNNoranda Income Fund108.272.140.85OLYOlympia Financial Group6.003.321.59XLYConsumer Discretionary Select Sector SPDR FundN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIMAIM ImmunoTech12.02%NIF.UNNoranda Income Fund8.18%OLYOlympia Financial Group1.17%XLYConsumer Discretionary Select Sector SPDR Fund69.93%Insider OwnershipCompanyInsider OwnershipAIMAIM ImmunoTech0.02%NIF.UNNoranda Income Fund12.61%OLYOlympia Financial Group34.63%XLYConsumer Discretionary Select Sector SPDR FundN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIMAIM ImmunoTech2072.29 million68.74 millionNot OptionableNIF.UNNoranda Income Fund53737.49 millionN/ANot OptionableOLYOlympia Financial Group3252.41 millionN/ANot OptionableXLYConsumer Discretionary Select Sector SPDR Fund147,00098.60 millionN/ANot OptionableNIF.UN, XLY, OLY, and AIM HeadlinesRecent News About These CompaniesWeekly Economic Snapshot: Inflation Cools While Sentiment Cautiously ClimbsJune 2 at 11:52 AM | etftrends.comShould You Invest in the Consumer Discretionary Select Sector SPDR ETF (XLY)?June 2 at 7:21 AM | zacks.comWeekly Economic Snapshot: Inflation Relief Meets Consumer WoesMay 19, 2025 | etftrends.com3 Dividend-Friendly Consumer Discretionary Stocks With UpsideMay 19, 2025 | dividendstocks.comMost and least shorted S&P 500 consumer discretionary stocks in AprilMay 18, 2025 | seekingalpha.com3 ETF Strategies to Follow on Temporary U.S.-China Trade DealMay 12, 2025 | zacks.comOil Slumps to Below $60: ETFs to GainMay 5, 2025 | zacks.comWeekly Economic Snapshot: Solid Jobs Amid GDP Contraction & Crashing ConfidenceMay 5, 2025 | etftrends.com7 of 17 S&P 500 consumer discretionary stocks beat estimates - Earnings ScoreboardMay 4, 2025 | msn.comPCE Report Preview: TLT, Sector ETFs in FocusApril 29, 2025 | finance.yahoo.comIs Weak Consumer Sentiment Hurting Discretionary ETFs?April 28, 2025 | zacks.comWeekly Economic Snapshot: Housing Divide Amid Plunging SentimentApril 28, 2025 | etftrends.comConsumer Stock Winners And Losers — Has Retail Sentiment Shifted After Volatile Week?April 21, 2025 | msn.comMost and least shorted S&P 500 consumer discretionary stocks in MarchApril 19, 2025 | msn.comHow To Invest In Different Sectors Of The Stock MarketApril 14, 2025 | news24online.comWeekly Economic Snapshot: Tariff Swings, Inflation Relief in the Rearview, & Sinking SentimentApril 14, 2025 | etftrends.comTaking Apart the Tariff Impact With ETFsApril 10, 2025 | etftrends.comTaking Apart the Tariff Impact With ETFsApril 10, 2025 | etftrends.comETF Prime: Islam Analyzes Tariffs Impact on ETFsApril 8, 2025 | etftrends.comDiagnosing the Market on Health Day: 6 ETFs Looking HealthyApril 7, 2025 | zacks.com3 Stocks Institutions Are Quietly Dumping (XLY)March 11, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s WatchingNavitas Soars on NVIDIA Deal: Breaking Down Its Tech and OutlookBy Leo Miller | May 27, 2025View Navitas Soars on NVIDIA Deal: Breaking Down Its Tech and Outlook3 Different Ways to Add Gold to Your PortfolioBy Chris Markoch | May 29, 2025View 3 Different Ways to Add Gold to Your PortfolioNIF.UN, XLY, OLY, and AIM Company DescriptionsAIM ImmunoTech NYSE:AIM$0.09 -0.03 (-22.34%) As of 04/4/2025 This is a fair market value price provided by Polygon.io. Learn more.AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente; Jubilant HollisterStier; Sterling Pharma Solutions; Erasmus University Medical Center Rotterdam; Azenova, LLC; and Alcami Corporation. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.Noranda Income Fund TSE:NIF.UNNoranda Income Fund operates as an income trust. The company owns electrolytic zinc processing facility and ancillary assets located in Salaberry-de-Valleyfield, Québec that produces refined zinc metal and various by-products from zinc concentrate. Its products include jumbo zinc, a product customized with alloy for steel customers to enhance the productivity of galvanizing lines; zinc shot, a product that is used to produce electro-galvanized steel for the car industry; and granulated zinc that is used in the production of fertilizers and reagents for the pulp and paper industry. The company's by-products comprise copper cake, cadmium, and sulphuric acid. It serves customers in Canada, the United States, and internationally. The company was founded in 1963 and is headquartered in Toronto, Canada.Olympia Financial Group TSE:OLYC$111.79 +1.79 (+1.63%) As of 03:59 PM EasternOlympia Financial Group Inc is engaged in providing financial services. The company's operating segments are Private Health Services Plan division which markets, sells and administers health and dental benefits to business owners; Investment Account Services division specializes in registered account administration; The Currency and Global Payments division provides corporations and private clients a personalized service for buying and selling foreign currencies; The Exempt Edge division is focused on Onboarding fees; The Corporate and Shareholder Services division, which acts as a cost centre and the Corporate Division.Consumer Discretionary Select Sector SPDR Fund NYSEARCA:XLY$214.30 +0.50 (+0.23%) Closing price 04:10 PM EasternExtended Trading$214.30 0.00 (0.00%) As of 05:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Consumer Discretionary Select Sector SPDR Fund seeks to provide investment results that correspond generally to the price and yield performance of the Consumer Discretionary Select Sector Index (the Index). The Index includes companies from the following industries, media; retail (specialty, multiline, Internet and catalog); hotels, restaurants and leisure; textiles, apparel and luxury goods; household durables; automobiles; auto components; distributors; leisure equipment and products; and diversified consumer services. The Fund's investment advisor is SSgA Funds Management, Inc. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Zscaler Will Hit $360 Soon: Here’s the How and Why Buy The Dip in Okta, There’s Nothing Wrong With the Outlook Why SoundHound Could Be a Short Squeeze in the Making Why Schwab US Dividend Equity ETF Could Lead the Rotation Analysts Are Bullish on Marvell Stock Despite Amazon Deal Concern MarketBeat Week in Review – 05/26 - 05/30 Super Micro Computer Stock Finding Upside With NVIDIA's Blackwell 5 Reasons Costco Stock Will Hit New Highs This Year Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
